About Dallas McMillan

Dallas McMillan is founder and President of Rhizo Sciences and leads the international hemp and cannabis activities. Recognised as a leading authority in production of truly medical grade cannabis, Dallas leads a team of agricultural, medical and pharmaceutical specialists with a passion for cannabis and hemp and the impact they can make on human health, the environment, and economies. Key to Rhizo Sciences' success in the industry has been an emphasis on leveraging proven technology, personnel and processes from traditional industries while honoring the unique value and characteristics of the cannabis plant and those who have worked tirelessly to bring it into the mainstream. Connect with Dallas on Linkedin or Email.

Rhizo Sciences to Export Medical Cannabis From Africa

By |2018-01-05T05:39:33+00:00Jan,18 2|Categories: International Cannabis|Tags: , , , , , , |

Rhizo Sciences announces Medical Cannabis Exports from Africa in Partnership with Medi Kingdom US firm targets international medical cannabis markets with $45M export partnership with first African medical cannabis producer. Seattle, December 14, 2017. Rhizo Sciences announces construction of 400,000 square foot export facility in Lesotho, Africa to meet growing international demand for medical cannabis. Rhizo [...]

Terpenes and the Entourage Effect

By |2017-08-06T03:48:39+00:00Aug,17 6|Categories: Terpenes|

Most animal studies with cannabidiol utilize synthetic, single-molecule CBD produced by biochemical laboratories for research purposes. In contrast, whole plant extractions typically include CBD, THC, and more than 400 trace compounds. Many of these compounds interact synergistically to create what scientists refer to as an “entourage effect” that magnifies the therapeutic benefits of the plant’s individual components—so that the medicinal [...]

Full Spectrum Cannabis Extracts Superior to CBD

By |2017-08-06T03:47:35+00:00Feb,15 22|Categories: Cannabis Extracts|Tags: , |

A groundbreaking study has documented the superior therapeutic properties of whole plant CBD-rich cannabis extract as compared to single-molecule CBD. BY MARTIN A. LEE ON FEBRUARY 22, 2015 A groundbreaking study from Israel has documented the superior therapeutic properties of whole plant CBD-rich cannabis extract as compared to single-molecule cannabidiol (CBD). Published in the journal Pharmacology &Pharmacy (Feb. 2015), the article directly challenges one [...]